Kymera Therapeutics (NASDAQ:KYMR) Trading Down 4.4%

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating)’s stock price fell 4.4% during mid-day trading on Thursday . The company traded as low as $28.10 and last traded at $28.25. 249,544 shares were traded during mid-day trading, a decline of 52% from the average session volume of 517,368 shares. The stock had previously closed at $29.56. […]

Related Keywords

,Nasdaq ,Avoro Capital Advisors ,Wells Fargo Company ,Credit Suisse Group ,Pricet Rowe Associates Inc ,Venture Fund Xlp Atlas ,Securities Exchange Commission ,Blackrock Inc ,Morgan Stanley ,Goldman Sachs Group ,Kymera Therapeutics Inc ,Kymera Therapeutics ,Get Rating ,Suisse Group ,Therapeutics Trading Down ,Venture Fund ,Exchange Commission ,Director Bvf Partners ,Capital Advisors ,Street Corp ,Kymera Therapeutics Daily ,Nasdaq Kymr ,Kymr ,Medical ,Stocks ,Technicals ,